newsfilter
← Latest News
GlobeNewswire·

Chiasma to Host an Expert Panel on Acromegaly and the MPOWERED® Phase 3 Trial Results

NEEDHAM, Mass., Nov. 20, 2020 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a commercial-stage biopharmaceutical company utilizing its delivery platform technology to develop and commercialize...